Injection of 3×106 Mz-ChA-1
cells +/− GABA intratumoral injection |
GABA inhibits CCA growth in vivo |
Fava et al., [47] |
Injection of 3×106 Mz-IL-6
cells |
IL-6 overexpression increases CCA xenograft
tumor growth |
Meng et al., [53] |
Injection of 2×106 QBC939
cells +/− magnetic nanoparticle injections |
Magnetic nanoparticles inhibit CCA tumor
growth |
Tang et al., [61] |
Injection of 5×106 Sk-ChA-1
cells +/− intratumoral tamoxifen injection |
Intratumoral tamoxifen injections decrease CCA
growth |
Pawar et al., [57] |
Injection of 5×106 Mz-ChA-1
cells +/− green tea polyphenol EGCG i.p injection |
EGCG decreases CCA tumor growth and increases
tumor sensitivity to gemcitabine |
Lang et al., [52] |
Injection of 5×106 Mz-ChA-1
cells expressing Il-6 |
Overexpression of Il-6 increases DNMT-1
expression in CCA |
Braconi et al., [45] |
Injection of 5×106 Mz-ChA-1
cells +/− resveratrol i.p injection |
Resveratrol decreases Cyp1b1 expression in CCA
tumors |
Frampton et al., [48] |
Injection of 5×106 Mz-ChA-1
cells +/− intratumoral anti-NYP antibody injection |
NPY decreases CCA tumor growth |
DeMorrow et al., [46] |
Injection of 2×106 QBC939
cells +/− wortmannin i.p injection or
+/− AdSi-beclin intratumor injection |
Treatment with an autophagy inhibitor or
knockdown of beclin-1 suppressed CCA xenograft tumor growth |
Hou et al., [49] |
Injection of M139 CypA-silenced CCA cell
lines |
CypA silencing decreases CCA xenograft tumor
growth |
Obchoei et al., [55] |
Injection of HuCCT1 cell line overexpressing
miR494 |
miR494 decreases CCA xenograft tumor
growth |
Olaru et al., [56] |
Injection of 1,5×106 CCLP1
cells +/− miR26-a overexpression |
miR-26a overexpression increases in vivo CCA
tumor growth |
Zhang et al., [62] |
Injection of 2×106 HuCCT-1
cells +/− WTAP-over or siWTAP |
WTAP overexpression increases CCA tumor growth
in an orthotopic xenograft model; WTAP knockdown decreases CCA tumor
growth |
Jo et al., [51] |
Injection of 3×106 CCLP1
cells +/− miR92a or miR-17-92 |
miR-19a overexpression induces CCA tumor
growth in vivo |
Zhu et al., [64] |
Injection of 1×107 QBC939
cells +/− intratumoral rapamycin/salubrinal
injection |
Salubrinal with rapamycin has a synergistic
antitumor effect in CCA |
Zhao et al., [63] |
Injection of 1×106 EGI1
cells +/− 1×107 Lent-SOX17
intratumoral injection |
SOX17 overexpression decreases CCA xenograft
tumor growth |
Merino-Azpitarte et al., [54] |
Injection of 5×106 HuCCT-1
cells +/−SC-43 gavage administration |
SC-43 induces apoptosis in CCA via the
SHP-1/STAT3 signaling pathway |
Hu et al., [50] |
Injection of 2×106 RBE
cells +/− NRP-1 depletion |
NRP- 1 depletion reduces tumor growth and
metastasis |
Zhu et al., [65] |
Injection of 3×106 HuCCT-1
cells +/− telmisartan i.p injection |
Telmisartan inhibits tumor growth in CCA |
Samukawa et al., [58] |
Injection of 1×107 RBE
cells +/− shPTHLHx |
Loss of PTHLH suppresses CCA
tumorigenesis |
Tang et al., [60] |
Injection of 2×106 TFK-1 or
HuCCT-1 cells +/− siAFAP1-AS1 |
AFAP1-AS1 is oncogenic in CCA |
Shi et al., [59] |